Drawing for COPAZONE

USPTO serial 74348962

COPAZONE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
BORSUK, ESTHER
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COPAZONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosisABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 20, 1994ABN5ABANDONMENT - AFTER PUBLICATION
Nov 22, 1993ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Oct 26, 1993PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 24, 1993NPUBNOTICE OF PUBLICATION
Jul 29, 1993CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 1993CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 1993CNSLLETTER OF SUSPENSION MAILED
Jun 16, 1993CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 1993CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 1993DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance